A Study of NVL-655 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
NCT 05384626 Brief Summary Phase 1/2, dose escalation and expansion study designed…
Read more arrow_forwardNCT 05384626 Brief Summary Phase 1/2, dose escalation and expansion study designed…
Read more arrow_forwardNCT 06326411 Brief Summary This is a two-part Phase 1, open label,…
Read more arrow_forwardNCT 05807035 Brief Summary Phase 1 trial to evaluate the feasibility of…
Read more arrow_forwardNCT 06219941 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 05598151 Brief Summary This is a Phase1 study to assess the…
Read more arrow_forwardNCT 05949684 Brief Summary The purpose of the study is to compare…
Read more arrow_forwardNCT 05086315 Brief Summary This is an open-label, multicenter, Phase 1/Phase 2,…
Read more arrow_forwardNCT 06465953 Brief Summary This study will enroll participants with myelodysplastic syndromes…
Read more arrow_forwardNCT 03486873 Brief Summary The purpose of this study is to…
Read more arrow_forwardACTRN 12622000410752 Brief Summary Traditionally, combination therapy has not proven to be…
Read more arrow_forward